# Biomarker Core

> **NIH NIH P30** · JOHNS HOPKINS UNIVERSITY · 2021 · $340,683

## Abstract

PROJECT SUMMARY – BIOMARKER CORE
The Johns Hopkins University NIMH Center for Novel Therapeutics for HIV-associated Cognitive Disorders
Biomarker Core will provide support for pre-clinical development and clinical testing associated with
therapeutics to treat cognitive disorders in HIV-infected patients. This support will include a series of measures
of neurobiological functions including cell stress, neuronal injury/protection, oxidative injury, energy
metabolism, immune activation and insulin signaling. These measures will be used to support experimental
outcome measures in pre-clinical projects, and will aid in determining the biological response to clinical stage
therapeutics.

## Key facts

- **NIH application ID:** 10118206
- **Project number:** 5P30MH075673-15
- **Recipient organization:** JOHNS HOPKINS UNIVERSITY
- **Principal Investigator:** Norman J Haughey
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $340,683
- **Award type:** 5
- **Project period:** 2006-04-01 → 2022-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10118206

## Citation

> US National Institutes of Health, RePORTER application 10118206, Biomarker Core (5P30MH075673-15). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/10118206. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*